Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 4,992

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis

Open access
Meijer, Laurent, Nelson, Deborah J., Riazanski, Vladimir, Gabdoulkhakova, Aida G., Hery-Arnaud, Geneviève, Le Berre, Rozenn, Loaëc, Nadège, Oumata, Nassima, Galons, Hervé, Nowak, Emmanuel, Gueganton, Laetitia, Dorothée, Guillaume, Prochazkova, Michaela, Hall, Bradford, Kulkarni, Ashok B., Gray, Robert D., Rossi, Adriano G., Witko-Sarsat, Véronique, Norez, Caroline, Becq, Frédéric, Ravel, Denis, Mottier, Dominique, Rault, Gilles·2016·Journal of Innate Immunity

Abstract

(R)-Roscovitine, a pharmacological inhibitor of kinases, is currently in phase II clinical trial as a drug candidate for the treatment of cancers, Cushing's disease and rheumatoid arthritis. We here review the data that support the investigation of (R)-roscovitine as a potential therapeutic agent for the treatment of cystic fibrosis (CF). (R)-Roscovitine displays four independent properties that may favorably combine against CF: (1) it partially protects F508del-CFTR from proteolytic degradation and favors its trafficking to the plasma membrane; (2) by increasing membrane targeting of the TRPC6 ion channel, it rescues acidification in phagolysosomes of CF alveolar macrophages (which show abnormally high pH) and consequently restores their bactericidal activity; (3) its effects on neutrophils (induction of apoptosis), eosinophils (inhibition of degranulation/induction of apoptosis) and lymphocytes (modification of the Th17/Treg balance in favor of the differentiation of anti-inflammatory lymphocytes and reduced production of various interleukins, notably IL-17A) contribute to the resolution of inflammation and restoration of innate immunity, and (4) roscovitine displays analgesic properties in animal pain models. The fact that (R)-roscovitine has undergone extensive preclinical safety/pharmacology studies, and phase I and II clinical trials in cancer patients, encourages its repurposing as a CF drug candidate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000444256

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 227

  1. 10.1152/ajplung.00335.2013 · DOI · Paper page
  2. 10.1007/s10096-013-1876-y · DOI
  3. 10.1513/AnnalsATS.201402-050AS · DOI · Paper page
  4. 10.2217/fmb.14.42 · doi:10.2217/fmb.14.42
  5. 10.1155/2013/645653 · DOI
  6. 10.1002/ppul.23247 · DOI
  7. 10.1002/ppul.23243 · DOI
  8. 10.1016/j.biocel.2014.01.017 · DOI
  9. 10.1159/000350215 · doi:10.1159/000350215
  10. 10.1016/j.jcf.2012.07.003 · DOI · Paper page
  11. 10.1056/NEJMc1502191 · DOI
  12. 10.1136/thoraxjnl-2015-207020 · DOI · Paper page
  13. 10.1002/ppul.23242 · DOI · Paper page
  14. 10.7326/M13-0636 · DOI · Paper page
  15. 10.1016/j.tips.2012.11.006 · DOI
  16. 10.4155/fmc.14.67 · DOI
  17. 10.1016/j.pharmthera.2014.06.005 · DOI · Paper page
  18. 10.2174/1389450115999141030144247 · DOI
  19. 10.1517/14728214.2014.882316 · DOI
  20. 10.1038/nrg3849 · DOI · Paper page
  21. 10.1517/13543776.2015.1045878 · DOI
  22. 10.1002/ppul.23240 · DOI
  23. 10.1002/ppul.23253 · DOI
  24. 10.1111/j.1432-1033.1997.t01-2-00527.x · DOI · Paper page
  25. 10.1111/j.1432-1033.1997.0518a.x · DOI · Paper page
  26. 10.1021/ar0201198 · doi:10.1021/ar0201198
  27. 10.1517/13543780903418445 · DOI
  28. 10.1016/S0165-6147(02)02071-0 · DOI · Paper page
  29. 10.1038/ncb1109-1275 · DOI · Paper page
  30. 10.1242/dev.091744 · DOI · Paper page
  31. 10.1074/jbc.M500806200 · DOI · Paper page
  32. 10.1074/jbc.M500805200 · DOI
  33. 10.1038/onc.2013.513 · DOI
  34. 10.1021/jm049323m · DOI · Paper page
  35. 10.1177/1947601910369817 · DOI
  36. 10.1021/op800284k · DOI
  37. 10.1371/journal.pone.0012117 · DOI
  38. 10.1016/j.nbd.2011.10.011 · DOI
  39. 10.1038/jcbfm.2011.117 · DOI
  40. 10.1128/JVI.76.15.7874-7882.2002 · DOI
  41. 10.1038/nature05348 · DOI · Paper page
  42. 10.4161/cc.22375 · DOI
  43. 10.1172/JCI119793 · DOI
  44. 10.1097/01.ASN.0000124672.41036.F4 · doi:10.1097/01.asn.0000124672.41036.f4
  45. 10.1111/j.1523-1755.2005.00213.x · DOI
  46. 10.1002/art.22593 · DOI
  47. 10.1517/17460441.2015.1000857 · DOI
  48. 10.1021/ml3002083 · DOI
  49. 10.1111/nyas.12001 · doi:10.1111/nyas.12001
  50. 10.1523/JNEUROSCI.5839-12.2013 · DOI
  51. 10.1096/fj.03-0035fje · doi:10.1096/fj.03-0035fje
  52. 10.1038/nature09855 · DOI · Paper page
  53. 10.1038/nm.2576 · DOI · Paper page
  54. 10.1371/journal.pone.0048560 · DOI
  55. 10.1073/pnas.1018091108 · DOI
  56. 10.1210/jc.2015-1606 · DOI
  57. 10.2170/physiolsci.RP006607 · DOI
  58. 10.1038/sj.bjc.6603509 · DOI · Paper page
  59. 10.1016/j.ejca.2010.08.001 · DOI
  60. 10.1158/1078-0432.CCR-08-1748 · doi:10.1158/1078-0432.ccr-08-1748
  61. 10.1095/biolreprod66.4.895 · DOI · Paper page
  62. 10.1530/REP-07-0069 · doi:10.1530/rep-07-0069
  63. 10.1016/j.ejps.2005.02.001 · DOI
  64. 10.1038/nm1468 · DOI · Paper page
  65. 10.2119/molmed.2012.00033 · DOI
  66. 10.1097/SHK.0b013e3182656e7b · DOI
  67. 10.4161/cbt.4.1.1462 · doi:10.4161/cbt.4.1.1462
  68. 10.1111/bph.12859 · DOI
  69. 10.1073/pnas.1518966112 · DOI
  70. 10.1074/mcp.M111.016626 · DOI
  71. 10.2174/156802611795589601 · doi:10.2174/156802611795589601
  72. 10.1038/ncb1456 · DOI · Paper page
  73. 10.1371/journal.pone.0019970 · DOI · Paper page
  74. 10.1038/352070a0 · DOI · Paper page
  75. 10.1038/nm1748 · DOI · Paper page
  76. 10.1074/jbc.M109.057372 · DOI · Paper page
  77. 10.1099/mic.0.2008/023200-0 · DOI
  78. 10.4049/jimmunol.0902851 · DOI
  79. 10.1189/jlb.0412188 · DOI
  80. 10.1152/ajpcell.00605.2005 · DOI
  81. 10.1074/jbc.M705296200 · DOI
  82. 10.1074/jbc.M809161200 · DOI
  83. 10.1091/mbc.E09-01-0061 · DOI
  84. 10.1083/jcb.200911083 · DOI · Paper page
  85. 10.1126/science.1163600 · DOI · Paper page
  86. 10.1152/ajplung.90203.2008 · DOI
  87. 10.1172/JCI34773 · DOI · Paper page
  88. 10.1126/scitranslmed.3001130 · DOI
  89. 10.1074/jbc.M511030200 · DOI
  90. 10.1021/bi060490t · DOI · Paper page
  91. 10.1189/jlb.1009655 · DOI
  92. 10.1189/jlb.0907658 · DOI
  93. 10.1517/13543776.2012.696099 · DOI
  94. 10.1016/j.pharmthera.2011.03.005 · DOI
  95. 10.2174/1568026611313030008 · doi:10.2174/1568026611313030008
  96. 10.1124/pr.113.008268 · DOI · Paper page
  97. 10.1007/978-3-319-05161-1_12 · DOI
  98. 10.1111/bph.12723 · doi:10.1111/bph.12723
  99. 10.1042/BJ20021975 · doi:10.1042/bj20021975
  100. 10.1016/S0143-4160(03)00058-7 · DOI · Paper page
  101. 10.1182/blood-2005-09-3803 · DOI
  102. 10.1111/j.1748-1716.2008.01918.x · DOI
  103. 10.1165/rcmb.2008-0373OC · DOI
  104. 10.1038/ncomms1660 · DOI · Paper page
  105. 10.1111/j.1365-2222.2008.03043.x · DOI
  106. 10.2174/138920111793937943 · doi:10.2174/138920111793937943
  107. 10.1096/fj.07-8110com · DOI
  108. 10.1165/rcmb.2009-0347OC · DOI
  109. 10.3389/fphar.2011.00067 · DOI
  110. 10.1007/s00005-011-0113-6 · DOI
  111. 10.1165/rcmb.2012-0502OC · DOI
  112. 10.1159/000346568 · DOI
  113. 10.1182/blood-2014-02-555268 · DOI · Paper page
  114. 10.1371/journal.pone.0106813 · DOI
  115. 10.1126/scitranslmed.3001201 · DOI · Paper page
  116. 10.1126/scitranslmed.3005580 · DOI · Paper page
  117. 10.1159/000363242 · DOI · Paper page
  118. 10.1016/j.jcf.2011.09.008 · DOI · Paper page
  119. 10.1371/journal.pone.0028526 · DOI · Paper page
  120. 10.1371/journal.pone.0023637 · DOI · Paper page
  121. 10.4049/jimmunol.1301589 · DOI
  122. 10.1165/rcmb.2011-0380OC · DOI
  123. 10.1016/j.imlet.2014.03.003 · DOI
  124. 10.1182/blood-2010-06-290171 · DOI · Paper page
  125. 10.1083/jcb.201006052 · DOI · Paper page
  126. 10.1172/JCI76009 · DOI
  127. 10.1083/jcb.200806072 · DOI · Paper page
  128. 10.1371/journal.pone.0029318 · DOI · Paper page
  129. 10.1152/ajpcell.00108.2013 · DOI · Paper page
  130. 10.4049/jimmunol.1102404 · DOI · Paper page
  131. 10.1038/nm.2715 · DOI · Paper page
  132. 10.1016/j.clinbiochem.2013.12.020 · DOI
  133. 10.1016/j.jcf.2008.10.002 · DOI
  134. 10.1016/j.jcf.2015.03.003 · DOI · Paper page
  135. 10.3390/antibiotics4010062 · DOI
  136. 10.3389/fimmu.2014.00378 · DOI
  137. 10.1159/000365399 · DOI
  138. 10.1111/j.1476-5381.2009.00402.x · DOI
  139. 10.1100/tsw.2010.169 · DOI
  140. 10.1038/cdd.2012.80 · DOI
  141. 10.1002/eji.200939664 · DOI
  142. 10.1177/1947601910369817 · DOI
  143. 10.1152/ajpcell.00138.2009 · DOI
  144. 10.1111/j.1365-2184.2009.00584.x · DOI
  145. 10.1158/1078-0432.CCR-12-2170 · DOI
  146. 10.1189/jlb.0409255 · DOI
  147. 10.1189/jlb.0909647 · DOI
  148. 10.1371/journal.ppat.1000461 · DOI · Paper page
  149. 10.1111/j.1476-5381.2011.01309.x · DOI
  150. 10.1165/ajrcmb.20.4.3371 · DOI
  151. 10.1080/09629359990658 · DOI
  152. 10.1097/MOH.0000000000000009 · DOI
  153. 10.1136/thx.2007.082388 · DOI
  154. 10.1016/j.jcf.2012.07.003 · DOI · Paper page
  155. 10.1159/000350215 · doi:10.1159/000350215
  156. 10.4049/jimmunol.0803312 · DOI
  157. 10.1136/thx.2008.096834 · doi:10.1136/thx.2008.096834
  158. 10.1159/000295791 · doi:10.1159/000295791
  159. 10.1371/journal.pone.0079352 · DOI
  160. 10.1073/pnas.96.23.13330 · DOI · Paper page
  161. 10.1016/0091-6749(91)92156-U · DOI
  162. 10.1136/thx.49.5.496 · doi:10.1136/thx.49.5.496
  163. 10.1111/cea.12595 · DOI · Paper page
  164. 10.1164/ajrccm/145.6.1477 · DOI · Paper page
  165. 10.1164/ajrccm.152.2.7633718 · DOI
  166. 10.1046/j.1365-2222.1998.00216.x · DOI
  167. 10.1016/0091-6749(88)90931-1 · DOI · Paper page
  168. 10.1046/j.1365-2222.2000.00988.x · DOI
  169. 10.1111/j.1365-2222.2010.03680.x · DOI
  170. 10.1111/imm.12416 · doi:10.1111/imm.12416
  171. 10.1074/jbc.M103776200 · DOI
  172. 10.1074/jbc.M312711200 · DOI
  173. 10.1016/j.febslet.2009.07.017 · DOI
  174. 10.3389/fimmu.2014.00302 · DOI
  175. 10.1371/journal.pone.0025683 · DOI
  176. 10.1164/rccm.201408-1565OC · DOI
  177. 10.1038/ni.3031 · DOI · Paper page
  178. 10.1186/1465-9921-14-138 · DOI
  179. 10.1371/journal.pone.0120912 · DOI
  180. 10.1164/rccm.201206-1150OC · DOI · Paper page
  181. 10.1164/rccm.201102-0236OC · DOI
  182. 10.1186/1465-9921-11-177 · DOI
  183. 10.1007/s00011-007-6187-2 · DOI
  184. 10.1164/rccm.201207-1346OC · DOI
  185. 10.1172/JCI42388 · DOI
  186. 10.3109/08820139.2014.888447 · doi:10.3109/08820139.2014.888447
  187. 10.1164/rccm.201407-1381OC · DOI
  188. 10.1016/j.diabres.2014.03.002 · doi:10.1016/j.diabres.2014.03.002
  189. 10.1164/rccm.201212-2201ED · DOI
  190. 10.1136/thoraxjnl-2013-203307 · DOI
  191. 10.1016/j.bbrc.2013.04.096 · DOI
  192. 10.1371/journal.pone.0081154 · doi:10.1371/journal.pone.0081154
  193. 10.4161/cc.8.11.8738 · DOI
  194. 10.1016/j.cellimm.2014.05.004 · DOI
  195. 10.7554/eLife.05920 · DOI
  196. 10.1016/j.bmcl.2006.04.042 · DOI
  197. 10.1016/j.jcf.2013.04.001 · DOI
  198. 10.1097/MEG.0000000000000011 · doi:10.1097/meg.0000000000000011
  199. 10.1016/j.ddstr.2009.04.004 · DOI
  200. 10.1073/pnas.0510405103 · DOI

200 of 227 shown

Cited by

See all 4,992

Metadata

Authors
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., Gueganton, L., Dorothée, G., Prochazkova, M., Hall, B., Kulkarni, A. B., Gray, R. D., Rossi, A. G., Witko-Sarsat, V., Norez, C., Becq, F., Ravel, D., Mottier, D., & Rault, G.
Venue
Journal of Innate Immunity
Publisher
S. Karger AG
Published
2016
Volume
8
Issue
4
Pages
330-349
ISSN
  • 1662-811X (ISSN-L)
  • 1662-8128
OpenAlex
W2301131921
Cited by
4,992
References
8
FWCI
438.81
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis. https://app.cochat.ai/papers/10.1159/000444256
The paper
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., Gueganton, L., Dorothée, G., Prochazkova, M., Hall, B., Kulkarni, A. B., Gray, R. D., Rossi, A. G., Witko-Sarsat, V., Norez, C., . . . Rault, G. (2016). Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis. Journal of Innate Immunity. https://doi.org/10.1159/000444256

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.